Home > Animal Health & Nutrition > Veterinary Services > Veterinary CRO and CDMO Market

Veterinary CRO and CDMO Market Share

Report ID: GMI10318
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Veterinary CRO and CDMO Market Share

The market is characterized by a diverse range of providers offering specialized services in drug development, manufacturing, and regulatory support for veterinary pharmaceuticals. These companies compete based on their expertise in clinical trial management, formulation development, and adherence to global regulatory standards. Further, the key factors influencing competition include technological capabilities, geographic reach, regulatory expertise, and the ability to tailor services to meet the evolving needs of clients in the animal health sector.

Veterinary CRO and CDMO Market Companies

Few of the prominent players operating in the veterinary CRO and CDMO industry include:

Argenta Holdco Ltd.
Clinvet
Eva Pharma
Huvepharma
IDEXX Laboratories, Inc.
KLIFOVET GmbH
löhlein and wolf vet research
Mercurio HoldCo Ltd.
Moredun Foundation
Syngene International Ltd.
Tekro Ltd.
Triveritas
Uniivo
Vetio

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The veterinary contract research organization and contract development and manufacturing organization industry size was USD 6.2 billion in 2023 and will grow at 8.7% CAGR through 2032 due to the increasing prevalence of diseases in animals such as cancer and zoonotic infections.

The CDMO services segment recorded 85.5% of the market share in 2023 as pharmaceutical and biotechnology companies increasingly rely on specialized services to manage essential aspects of the veterinary drug lifecycle.

U.S. veterinary CRO and CDMO industry size was USD 2.2 billion in 2023 driven by high pet ownership rates, and significant investment in R&D.

Argenta Holdco Ltd., Clinvet, Eva Pharma, Huvepharma, IDEXX Laboratories, Inc., KLIFOVET GmbH, löhlein and wolf vet research, Mercurio HoldCo Ltd., Moredun Foundation, Syngene International Ltd., and Tekro Ltd.